IART
$13.33-0.89%
Integra LifeSciences Holdings CorporationStock · HealthcareRussell 2000 · 0.04% of IWMRussell 3000 · 0.002% of IWVUS Stock Market · 0.002% of VTI
IART financial statements
The full income statement, balance sheet, and cash-flow statement for Integra LifeSciences Holdings Corporation (IART), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 77.6M2024-09 77.2M2024-12 77.2M2025-03 77.7M2025-06 77.9M2025-09 77.9M2025-12 77.9M2026-03 77.8M2026-06 77.8M+0.2% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
PeriodRangeOrderChangeFiguresAs-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 1.64B+1.5% | 1.61B+4.5% | 1.54B-1.0% | 1.56B+1.0% | 1.54B+12.4% | |
| Cost of revenue | 804M+10.3% | 728M+10.9% | 657M+11.8% | 587M-1.7% | 598M+14.8% | |
| Research & development | 99.0M-14.2% | 115M+10.7% | 104M+3.0% | 101M+8.8% | 93.1M+20.3% | |
| Selling, general & administrative | 700M-2.4% | 717M+9.2% | 657M+6.5% | 616M-3.3% | 637M+7.2% | |
| Amortization of intangibles | 15.0M-29.8% | 21.3M+72.0% | 12.4M-10.8% | 13.9M-17.9% | 16.9M-39.1% | |
| Provision for credit losses | 3.20M-5.9% | 3.40M+13.3% | 3.00M+1400.0% | 200K+118.2% | -1.10M-130.6% | |
| Operating income | -493M-1836.5% | 28.4M-74.5% | 112M-53.3% | 239M+21.1% | 197M+30.3% | |
| Interest expense | 86.3M+22.1% | 70.6M+37.5% | 51.4M+3.6% | 49.6M-1.6% | 50.4M-29.6% | |
| Interest & investment income | 18.5M-7.8% | 20.0M+16.5% | 17.2M+44.3% | 11.9M+76.9% | 6.74M-27.5% | |
| Other non-operating income | -2.35M-159.6% | 3.94M+6.1% | 3.72M-69.0% | 12.0M-37.8% | 19.3M+335.4% | |
| Pre-tax income | -564M-2989.9% | -18.2M-122.5% | 81.1M-62.1% | 214M-0.4% | 215M+129.6% | |
| Income tax | -47.0M-316.4% | -11.3M-184.7% | 13.3M-60.0% | 33.3M-26.9% | 45.6M+213.0% | |
| Net income | -516M-7337.7% | -6.94M-110.3% | 67.7M-62.5% | 181M+6.8% | 169M+26.3% | |
| -$6.74-7388.9% | -$0.09-110.7% | $0.84-61.1% | $2.16+9.1% | $1.98+26.1% | ||
| EPS (basic) | -$6.74-7388.9% | -$0.09-110.6% | $0.85-61.0% | $2.18+9.0% | $2.00+26.6% | |
| Weighted-avg shares (basic) | 76.7M-0.4% | 77.0M-3.8% | 80.1M-3.5% | 83.0M-2.0% | 84.7M+0.1% | |
| Weighted-avg shares (diluted) | 76.7M-0.4% | 77.0M-4.1% | 80.3M-3.8% | 83.5M-2.3% | 85.5M+0.3% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 1.16B+7.2% | 1.08B+2.2% | 1.06B-8.9% | 1.16B+0.7% | 1.15B-6.7% | ||
| Cash & equivalents | 235M-4.6% | 246M-10.9% | 276M-39.5% | 457M-11.1% | 513M+9.2% | |
| Short-term investments | 28.7M+5.5% | 27.2M-16.8% | 32.7M | 0.00 | — | |
| Accounts receivable | 279M+2.4% | 272M+5.0% | 259M-1.6% | 263M+13.6% | 232M+2.8% | |
| Inventory | 493M+14.8% | 429M+10.1% | 390M+20.0% | 325M+2.3% | 317M+2.3% | |
| Prepaid expenses | 96.1M+24.8% | 77.0M+14.3% | 67.4M-42.3% | 117M+28.3% | 91.1M+31.4% | |
| Other current assets | 28.1M-5.1% | 29.7M-9.2% | 32.6M+5.2% | 31.0M | — | |
| 3.60B-10.8% | 4.04B+6.8% | 3.78B-2.8% | 3.89B+2.8% | 3.78B+4.6% | ||
| Property, plant & equipment | 444M+9.5% | 406M+19.3% | 340M+9.3% | 311M-0.1% | 312M+8.4% | |
| Operating lease right-of-use | 141M-2.4% | 144M-7.8% | 156M+5.3% | 148M+75.4% | 84.5M+1.1% | |
| Goodwill | 615M-43.9% | 1.10B+3.9% | 1.06B+1.6% | 1.04B+2.5% | 1.01B+8.7% | |
| Intangible assets | 1.13B-6.0% | 1.21B+13.1% | 1.07B-5.2% | 1.13B-1.7% | 1.15B+15.8% | |
| Deferred tax assets | 69.9M+100.0% | 34.9M-24.2% | 46.1M+0.2% | 46.0M-19.2% | 57.0M-22.7% | |
| Other non-current assets | 37.9M-43.1% | 66.5M+14.3% | 58.2M+1.8% | 57.2M+247.9% | 16.4M+45.8% | |
| 456M-50.6% | 922M+200.4% | 307M-4.3% | 321M-5.6% | 340M-15.2% | ||
| Accounts payable | 95.7M+16.0% | 82.5M-10.6% | 92.3M-9.6% | 102M+65.1% | 61.8M+13.2% | |
| Accrued liabilities | 130M+7.0% | 122M+20.9% | 101M+26.0% | 80.0M-33.6% | 120M+27.9% | |
| Deferred revenue | 11.5M+9.3% | 10.5M+22.8% | 8.54M+17.7% | 7.25M+37.0% | 5.29M+0.4% | |
| Current lease liability | 14.0M-3.6% | 14.5M-4.9% | 15.3M+4.5% | 14.6M-1.0% | 14.8M+15.3% | |
| 2.56B+2.7% | 2.49B+13.6% | 2.19B+5.2% | 2.09B-0.6% | 2.10B-0.1% | ||
| Long-term debt | 727M-4.5% | 760M-1.9% | 775M+0.0% | 775M-8.1% | 844M-3.8% | |
| Deferred revenue (non-current) | 11.5M+25.0% | 9.20M+19.5% | 7.70M-12.5% | 8.80M+31.3% | 6.70M+0.0% | |
| Non-current lease liability | 163M-2.3% | 167M+0.0% | 167M+6.0% | 157M+74.3% | 90.3M+2.5% | |
| Operating lease liability (total) | 177M-2.4% | 181M-0.4% | 182M+5.9% | 172M+63.7% | 105M+4.1% | |
| Deferred tax liabilities | 5.66M-90.7% | 60.8M+72.2% | 35.3M-44.2% | 63.3M+38.3% | 45.8M+182.8% | |
| Other non-current liabilities | 204M+39.7% | 146M-26.9% | 200M+44.4% | 139M+15.2% | 120M-35.6% | |
| 1.04B-32.5% | 1.55B-2.7% | 1.59B-12.0% | 1.80B+7.1% | 1.68B+11.2% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock | 923K+0.8% | 916K+0.8% | 909K+0.4% | 905K+1.0% | 896K+0.3% | |
| Additional paid-in capital | 1.34B+1.1% | 1.32B+1.6% | 1.30B+2.0% | 1.28B+1.0% | 1.26B-2.0% | |
| Retained earnings | 423M-54.9% | 940M-0.7% | 947M+7.7% | 879M+25.8% | 699M+31.2% | |
| Treasury stock | 689M-0.3% | 691M+6.8% | 647M+78.4% | 363M+54.8% | 234M-0.3% | |
| Accumulated other comprehensive income | -30.1M-9.1% | -27.6M-82.5% | -15.1M-247.2% | 10.3M+122.7% | -45.2M+39.0% | |
| Total liabilities & equity | 3.60B-10.8% | 4.04B+6.8% | 3.78B-2.8% | 3.89B+2.8% | 3.78B+4.6% | |
| Common shares issued | 92.3M+0.7% | 91.6M+0.8% | 90.9M+0.5% | 90.5M+1.0% | 89.6M+0.4% | |
| Shares outstanding (cover) | 77.9M+0.9% | 77.2M-1.3% | 78.2M-4.2% | 81.6M-1.9% | 83.2M-1.3% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 50.4M-61.1% | 129M-7.6% | 140M-47.1% | 264M-15.4% | 312M+53.3% | ||
| Depreciation & amortization | 59.8M-6.2% | 63.7M+19.5% | 53.3M-1.3% | 54.0M-4.1% | 56.3M-19.4% | |
| Intangible amortization | 15.0M-29.8% | 21.3M+72.0% | 12.4M-10.8% | 13.9M-17.9% | 16.9M-39.1% | |
| Share-based compensation | 18.6M-23.8% | 24.4M+21.0% | 20.1M-27.3% | 27.7M-23.4% | 36.2M+84.8% | |
| Deferred income taxes | -66.3M-219.6% | -20.7M-74.4% | -11.9M-159.2% | -4.58M-66.4% | -2.75M+95.7% | |
| Change in receivables | 485K+106.6% | -7.40M-61.1% | -4.59M-113.5% | 33.9M+566.7% | -7.26M+86.1% | |
| Change in inventory | 46.8M+66.1% | 28.1M-52.9% | 59.8M+105.2% | 29.1M+641.9% | -5.37M-111.1% | |
| -108M+72.3% | -391M-315.0% | -94.2M-60.8% | -58.6M+63.7% | -161M-137.2% | ||
| Capital expenditure | 81.4M-22.0% | 104M+56.2% | 66.9M+57.9% | 42.3M-11.8% | 48.0M+23.5% | |
| Free cash flow | -31.1M-224.4% | 25.0M-65.8% | 73.1M-67.1% | 222M-16.0% | 264M+60.3% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Purchases of investments | 8.50M-82.6% | 49.0M+49.9% | 32.7M | 0.00 | 0.00 | |
| Proceeds from sale of PP&E | — | 0.00 | 0.00-100.0% | 11.1M+371400.0% | 3.00K-99.9% | |
| 28.3M-88.1% | 238M+203.5% | -230M+8.7% | -252M-156.5% | -98.2M-180.8% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 221K-99.6% | 52.5M-80.9% | 275M+120.0% | 125M | 0.00-100.0% | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| FX effect on cash | 18.0M+378.7% | -6.46M-266.2% | 3.89M+136.3% | -10.7M-13.2% | -9.48M-168.3% | |
| Net change in cash | -11.3M+62.3% | -30.0M+83.3% | -180M-217.4% | -56.8M-231.2% | 43.3M-84.0% | |
| Interest paid | 81.4M+26.4% | 64.4M+45.4% | 44.3M+5.0% | 42.2M-2.3% | 43.2M-8.7% | |
| Income taxes paid | 17.2M-24.2% | 22.7M-3.8% | 23.6M-34.3% | 35.9M-27.5% | 49.5M+66.1% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 968M-44.7% | 1.75B-48.6% | 3.40B-27.3% | 4.68B-16.0% | 5.58B+1.8% | |
| P/E | — | — | 33.8×+24.7% | 27.1×-17.9% | 33.0×-19.4% | |
| P/S | 0.6×-45.6% | 1.1×-50.7% | 2.2×-26.2% | 3.0×-17.2% | 3.6×-9.4% | |
| P/B | 0.9×-18.1% | 1.1×-47.4% | 2.2×-20.6% | 2.7×-18.0% | 3.3×-8.5% | |
| P/FCF | — | 70.2×+126.2% | 31.0×+27.9% | 24.3×+15.0% | 21.1×-36.5% | |
| Earnings yield | — | — | 3.0%-19.8% | 3.7%+21.8% | 3.0%+24.0% | |
| FCF yield | — | 1.4%-55.8% | 3.2%-21.8% | 4.1%-13.0% | 4.7%+57.5% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: IART’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all IART filings on SEC EDGAR → Not investment advice.